Clinical Trials for Prurigo Nodularis

Find clinical trials for prurigo nodularis. Discover research opportunities and treatment options in your area.

15 Active Trials Found

Showing 15 trials on this page

Page 1 of 1

Determinants of Chronic Inflammatory Skin Disease Trajectories

NCT ID: NCT05928169

This clinical trial, titled "Determinants of Chronic Inflammatory Skin Disease Trajectories," is studying how different factors affect the way chronic skin diseases, like atopic dermatitis, psorias...

Recruiting

Type: observational Locations: Kiel, , Germany

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

NCT ID: NCT06516965

This clinical trial, called STOP-PN2, is studying a medication called povorcitinib to see how well it works for people with prurigo nodularis, a skin condition that causes severe itching and bumps ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Bronx, New York, United States, Philadelphia, Pennsylvania, United States +168 more

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

NCT ID: NCT06516952

This clinical trial is studying a new medication called povorcitinib to see how well it helps people with prurigo nodularis, a condition that causes intense itching and skin bumps. The main goal is...

Recruiting

Phase: PHASE3 Type: interventional Locations: Saint Louis, Missouri, United States, Troy, Michigan, United States +168 more

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

NCT ID: NCT06988618

This clinical trial is looking at the real-world effectiveness of a medication called nemolizumab (also known as Nemluvio®) for adults with moderate to severe prurigo nodularis, a skin condition th...

Not yet recruiting

Type: observational Locations: East Syracuse, New York, United States, Birmingham, Alabama, United States +49 more

A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis

NCT ID: NCT06293053

This clinical trial is studying a medication called Dupilumab to see how it works and how safe it is for children and teens aged 6 months to under 18 years who have a skin condition called prurigo ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Tulsa, Oklahoma, United States, Rancho Santa Margarita, California, United States +21 more

A Study of Barzolvolimab in Patients With Prurigo Nodularis

NCT ID: NCT06366750

This clinical trial is studying a new treatment called barzolvolimab for adults with prurigo nodularis, a condition that causes itchy, raised nodules on the skin. The main goal is to see how effect...

Recruiting

Phase: PHASE2 Type: interventional Locations: Atlanta, Georgia, United States, Barcelona, , Spain +55 more

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT ID: NCT06342713

This clinical trial is studying a new drug called BGB-45035 to see how safe it is and how the body processes it. This is the first time BGB-45035 is being given to people, so researchers want to fi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shenyang, Liaoning, China, Chengdu, Sichuan, China +14 more

A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

NCT ID: NCT06527404

This clinical trial is studying a new treatment called rocatinlimab for people with prurigo nodularis, a skin condition that causes severe itching and bumps. The goal is to see if rocatinlimab is m...

Recruiting

Phase: PHASE3 Type: interventional Locations: Badalona, , Spain, Box Hill, Victoria, Australia +189 more

Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis

NCT ID: NCT06779136

This clinical trial, called a Phase III study, is evaluating the effectiveness and safety of a new medication called MG-K10 for people with prurigo nodularis, a skin condition that causes itchy bum...

Recruiting

Phase: PHASE3 Type: interventional Locations: Beijing, Bejing, China

Upadacitinib for Prurigo Nodularis

NCT ID: NCT06773403

This clinical trial is studying a medication called upadacitinib to see how well it works for people suffering from prurigo nodularis, a skin condition that causes itchy lumps. The trial is open to...

Recruiting

Phase: PHASE4 Type: interventional Locations: East Windsor, New Jersey, United States

Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis

NCT ID: NCT06554509

This clinical trial is studying a new treatment called SHR-1819 injection for adults with a condition known as Prurigo Nodularis, which causes itchy, raised bumps on the skin. The main goal of the ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project

NCT ID: NCT05316805

This clinical trial is focused on improving the diagnosis and treatment of type 2 inflammatory skin diseases, such as atopic dermatitis eczema and prurigo nodularis. The goal is to gather informati...

Recruiting

Type: observational Locations: Beijing, , China

Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life

NCT ID: NCT06427122

This clinical trial is studying the impact of a new treatment called EMD-U on the quality of life for patients suffering from atopic dermatitis or prurigo nodularis, especially those who experience...

Recruiting

Phase: NA Type: interventional Locations: Rotterdam, , Netherlands

Efficacy and Safety of Tofacitinib in Patients With Prurigo Nodularis

NCT ID: NCT06201715

This clinical trial is looking at a medication called tofacitinib to see how well it works and how safe it is for patients with prurigo nodularis, a condition that causes severe itching and bumps o...

Not yet recruiting

Phase: NA Type: interventional Locations: Hangzhou, Zhejiang, China

A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine

NCT ID: NCT06087627

This clinical trial is studying the long-term effects and safety of a medication called dupilumab (brand name Dupixent®) for people suffering from a skin condition known as prurigo nodularis, which...

Recruiting

Type: observational Locations: Berlin, , Germany, Adernach, , Germany +9 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions